Result of Preferential Subscription Rights Issue

AI SummaryClose X

Novacyt S.A. has successfully raised €784,736 through a preferential subscription rights issue, issuing 1,961,840 new ordinary shares at €0.40 each, following its acquisition of Southern Cross Diagnostics Pty Ltd. The offer was oversubscribed by 125.20%, with total demand reaching 2,456,286 new shares. Ardenna PTY Ltd subscribed for €478,526 and was allocated the remaining 1,041,348 unsubscribed shares, resulting in it holding 1.43% of the enlarged share capital. The net proceeds of approximately €579,736 will strengthen the company's balance sheet. Following the issue, the company's total share capital will be €4,839,205.87, comprising 72,588,088 ordinary shares. The equity per share is expected to slightly decrease from €0.67 to €0.66.

Disclaimer*

UK 100

Latest directors dealings